AstraZeneca weighs seeking full U.S. approval for COVID shot, skipping emergency-use application

AstraZeneca PLC could skip asking the Food and Drug Administration for emergency-use authorization for its Covid-19 vaccine, according to people familiar with the matter—and instead pursue the more time-intensive application for a full-fledged license to sell the shot.